These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 1680023

  • 1. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
    Bissery MC, Guénard D, Guéritte-Voegelein F, Lavelle F.
    Cancer Res; 1991 Sep 15; 51(18):4845-52. PubMed ID: 1680023
    [Abstract] [Full Text] [Related]

  • 2. [Taxotere: from yew's needles to clinical practice].
    Lavelle F, Gueritte-Voegelein F, Guenard D.
    Bull Cancer; 1993 Apr 15; 80(4):326-38. PubMed ID: 7909695
    [Abstract] [Full Text] [Related]

  • 3. Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
    Bissery MC, Vrignaud P, Lavelle F.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 13):3-16. PubMed ID: 8604451
    [Abstract] [Full Text] [Related]

  • 4. Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
    Bissett D, Setanoians A, Cassidy J, Graham MA, Chadwick GA, Wilson P, Auzannet V, Le Bail N, Kaye SB, Kerr DJ.
    Cancer Res; 1993 Feb 01; 53(3):523-7. PubMed ID: 8093854
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
    Bissery MC, Nguyen CH, Bisagni E, Vrignaud P, Lavelle F.
    Invest New Drugs; 1993 Nov 01; 11(4):263-77. PubMed ID: 8157469
    [Abstract] [Full Text] [Related]

  • 6. Preclinical antitumor activity of bizelesin in mice.
    Carter CA, Waud WR, Li LH, DeKoning TF, McGovren JP, Plowman J.
    Clin Cancer Res; 1996 Jul 01; 2(7):1143-9. PubMed ID: 9816280
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM, Laster WR, Abbott BJ, Venditti J, Baratta M.
    Cancer Res; 1975 Apr 01; 35(4):939-45. PubMed ID: 1116151
    [Abstract] [Full Text] [Related]

  • 8. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
    Bissery MC, Vrignaud P, Lavelle F, Chabot GG.
    Anticancer Drugs; 1996 Jun 01; 7(4):437-60. PubMed ID: 8826613
    [Abstract] [Full Text] [Related]

  • 9. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM, Otter GM, Schmid FA.
    Cancer Res; 1993 Feb 01; 53(3):587-91. PubMed ID: 8425192
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
    Wallace RE, Murdock KC, Angier RB, Durr FE.
    Cancer Res; 1979 May 01; 39(5):1570-4. PubMed ID: 427798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Colpaert F, Tarayre JP, Mouillard P, Fahy J, Hill BT.
    Cancer Chemother Pharmacol; 1998 May 01; 41(6):437-47. PubMed ID: 9554586
    [Abstract] [Full Text] [Related]

  • 15. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
    LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH.
    Cancer Res; 1990 Aug 15; 50(16):4900-5. PubMed ID: 2165850
    [Abstract] [Full Text] [Related]

  • 16. Preclinical evaluation of docetaxel (Taxotere).
    Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S.
    Semin Oncol; 1995 Apr 15; 22(2 Suppl 4):3-16. PubMed ID: 7740328
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Johnson RK, Inouye T, Goldin A, Stark GR.
    Cancer Res; 1976 Aug 15; 36(8):2720-5. PubMed ID: 1064466
    [Abstract] [Full Text] [Related]

  • 19. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.
    Dexter DL, Hesson DP, Ardecky RJ, Rao GV, Tippett DL, Dusak BA, Paull KD, Plowman J, DeLarco BM, Narayanan VL.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5563-8. PubMed ID: 4053030
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.
    Li LH, DeKoning TF, Kelly RC, Krueger WC, McGovren JP, Padbury GE, Petzold GL, Wallace TL, Ouding RJ, Prairie MD.
    Cancer Res; 1992 Sep 15; 52(18):4904-13. PubMed ID: 1516047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.